[go: up one dir, main page]

ZA200200311B - 2-amino-benzoxazinones for the treatment of herpes simplex virus. - Google Patents

2-amino-benzoxazinones for the treatment of herpes simplex virus.

Info

Publication number
ZA200200311B
ZA200200311B ZA200200311A ZA200200311A ZA200200311B ZA 200200311 B ZA200200311 B ZA 200200311B ZA 200200311 A ZA200200311 A ZA 200200311A ZA 200200311 A ZA200200311 A ZA 200200311A ZA 200200311 B ZA200200311 B ZA 200200311B
Authority
ZA
South Africa
Prior art keywords
benzoxazinones
amino
treatment
herpes simplex
simplex virus
Prior art date
Application number
ZA200200311A
Inventor
Masashi Kawanishi
Wataru Takahashi
Original Assignee
Searle & Co
Asahi Chemical Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co, Asahi Chemical Ind filed Critical Searle & Co
Publication of ZA200200311B publication Critical patent/ZA200200311B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/241,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA200200311A 1999-07-12 2002-01-14 2-amino-benzoxazinones for the treatment of herpes simplex virus. ZA200200311B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14295699P 1999-07-12 1999-07-12

Publications (1)

Publication Number Publication Date
ZA200200311B true ZA200200311B (en) 2003-01-14

Family

ID=22501956

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200200311A ZA200200311B (en) 1999-07-12 2002-01-14 2-amino-benzoxazinones for the treatment of herpes simplex virus.

Country Status (11)

Country Link
EP (1) EP1210088A4 (en)
JP (1) JP2003504334A (en)
KR (1) KR20020046273A (en)
CN (1) CN1481245A (en)
AU (2) AU774370B2 (en)
BR (1) BR0012380A (en)
CA (1) CA2378014A1 (en)
HK (1) HK1046862A1 (en)
MX (1) MXPA02000485A (en)
WO (1) WO2001003697A1 (en)
ZA (1) ZA200200311B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2066662E (en) * 2006-09-21 2013-02-13 Kyorin Seiyaku Kk Serine hydrolase inhibitors
US11980677B2 (en) * 2021-05-14 2024-05-14 The Procter & Gamble Company Wet wipes with a cellulosic substrate and gentle lotion

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985872A (en) * 1995-05-24 1999-11-16 G.D. Searle & Co. 2-amino-benzoxazinones for the treatment of viral infections

Also Published As

Publication number Publication date
WO2001003697A1 (en) 2001-01-18
KR20020046273A (en) 2002-06-20
CA2378014A1 (en) 2001-01-18
EP1210088A1 (en) 2002-06-05
HK1046862A1 (en) 2003-01-30
CN1481245A (en) 2004-03-10
AU6208900A (en) 2001-01-30
AU2004203884A1 (en) 2004-09-09
BR0012380A (en) 2002-08-27
JP2003504334A (en) 2003-02-04
EP1210088A4 (en) 2003-03-12
MXPA02000485A (en) 2004-09-10
AU774370B2 (en) 2004-06-24

Similar Documents

Publication Publication Date Title
IL129352A0 (en) Benzimidazole-2- carbamates for the treatment of viral infections and cancer
ZA200202461B (en) Compounds for the treatment of ischemia.
ZA9811507B (en) Combination effective for the treatment of impotence.
ZA200202822B (en) Oncolytic combinations for the treatment of cancer.
GB9709360D0 (en) Methods for the treatment of herpes virus infections
ZA973622B (en) Use of forms of hyaluronic acid (HA) for the treatment of cancer.
AU2001260834A1 (en) The treatment of herpes
ZA200105690B (en) Novel treatment.
AU1916601A (en) Oncolytic combinations for the treatment of cancer
AU1916501A (en) Oncolytic combinations for the treatment of cancer
ZA200205470B (en) Virus strains for the oncolytic treatment of cancer.
AU1917101A (en) Oncolytic combinations for the treatment of cancer
ZA200110539B (en) Oxazinocarbazoles for the treatment of CNS diseases.
AU1595001A (en) Oncolytic combinations for the treatment of cancer
ZA200200311B (en) 2-amino-benzoxazinones for the treatment of herpes simplex virus.
ZA200203166B (en) Treatment of cancer.
AU1595101A (en) Oncolytic combinations for the treatment of cancer
ZA200110046B (en) Therapeutic agents.
MXPA03004454A (en) Imidazolone derivatives for the treatment of viral diseases.
ZA200109120B (en) Use of Arylalkanoylpyridazines.
MXPA01010701A (en) Vaccine.
AU6896300A (en) Vaccines for the treatment of autoimmune disease
AU3698199A (en) Radioimmuno-pharmacon for treating the hiv-1 infection
ZA993346B (en) The treatment of viral infections.
ZA964250B (en) 2-amino-benzoxazinones for the treatment of viral infections.